Invasive candidiasis in ICU: Analysis of antifungal treatments in the French study AmarCand;Candidoses invasives en réanimation : analyse des traitements antifongiques au cours de l'enquête française AmarCand

Annales Francaises d'Anesthesie et de Reanimation

Volumn 27, Issue 12, 2008, Pages 999-1007

  Leroy, O ^a   Mira, J P ^b   Montravers, P ^c   Gangneux, J P ^d,e   Gouin, F ^f   Sollet, J P ^g   Carlet, J ^h   Reynes, J ⁱ   Rosenheim, M ^j   Regnier B ^c   Lortholary, O ^k,l  

^a CENTRE HOSPITALIER DE TOURCOING   (France)

^b INSERM   (France)

^c BICHAT HOSPITAL   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^f TIMONE HOSPITAL   (France)

^g CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^h SAINT JOSEPH HOSPITAL   (France)

ⁱ GUI DE CHAULIAC HOSPITAL   (France)

^j PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^k UNIVERSITÉ PARIS DESCARTES   (France)

^l CNRS   (France)

more..

Author keywords

Candida; Candidemia; Epidemiology; Intensive care

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; PYRROLE; VORICONAZOLE;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DOCUMENTATION; DOSE RESPONSE; DRUG USE; FEMALE; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT SELECTION; PHYSICIAN; PRACTICE GUIDELINE; PREDICTION; PROSPECTIVE STUDY; SPECIES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 57249103309     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2008.10.004     Document Type: Article

References (32)

1. Lamagni T.L., Evans B.G., Shigematsu M., and Johnson E.M. Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-1999). Epidemiol Infect 126 (2001) 397-414
2. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
3. Marchetti O., Bille J., Fluckiger U., Eggimann P., Ruef C., Garbino J., et al. Fungal Infection Network of Switzerland. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 38 (2004) 311-320
4. Gudlaugsson O., Gillespie S., Lee K., Vande Berg J., Hu J., Messer S., et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37 (2003) 1172-1177
5. Charles P.E., Doise J.M., Quenot J.P., Aube H., Dalle F., Chavanet P., et al. Candidemia in critically ill patients: difference of outcome between medical and surgical patients. Intensive Care Med 29 (2003) 2162-2169
6. Nolla-Salas J., Sitges-Serra A., Leon-Gil C., Martínez-González J., León-Regidor M.A., Ibáñez-Lucía P., et al. Candidemia in nonneutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 23 (1997) 23-30
7. Leleu G., Aegerter P., and Guidet B. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 17 (2002) 168-175
8. Almirante B., Rodriguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
9. Morrell M., Fraser V.J., and Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 (2005) 3640-3645
10. Parkins M.D., Sabuda D.M., Elsayed S., and Laupland K.B. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60 (2007) 613-618
11. Wingard J.R., Merz W.G., Rinaldi M.G., Johnson T.R., Karp J.E., and Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325 (1991) 1274-1277
12. Abi-Said D., Anaissie E., Uzun O., Raad I., Pinzcowski H., and Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24 (1997) 1122-1128
13. Bassetti M., Righi E., Costa A., Fasce R., Molinari M.P., Rosso R., et al. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6 (2006) 21
14. Blot S., Janssens R., Claeys G., Hoste E., Buyle F., De Waele J.J., et al. Effect of fluconazole consumption on long-term trends in candidal ecology. J Antimicrob Chemother 58 (2006) 474-477
15. Hope W., Morton A., and Eisen D.P. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 50 (2002) 56-65
16. o spécial).
17. Ascioglu S., Rex J.H., de Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
18. Le Gall J.R., Lemeshow S., and Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270 (1993) 2957-2963
19. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22 (1996) 707-710
20. McCabe W., and Jackson G. Gram-negative bacteremia: Etiology and ecology. Arch Intern Med 110 (1962) 847-855
21. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., et al. Infectious Diseases Society of America. Guidelines for treatment of candidiasis. Clin Infect Dis 38 (2004) 161-189
22. Shorr A.F., Lazarus D.R., Sherner J.H., Jackson W.L., Morrel M., Fraser V.J., et al. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med 35 (2007) 1077-1083
23. Schelenz S. Management of candidiasis in the intensive care unit. J. Antimicrob Chemother 61 (2008) i31-i34
24. Leroy O., Boussekey N., and Georges H. Indication, intérêts et limites de la désescalade antibiotique en réanimation. Reanimation 15 (2006) 159-167
25. Sinuff T., Cook D., Giacomini M., Heyland D., and Dodek P. Facilitating clinician adherence to guidelines in the intensive care unit: A multicenter, qualitative study. Crit Care Med 35 (2007) 2083-2089
26. Sinuff T., Patel R.V., Adhikari N.K., Meade M.O., Schünemann H.J., and Cook D.J. Quality of professional society guidelines and consensus conference statements in critical care. Crit Care Med 36 (2008) 1049-1058
27. Navaratnam P., Jayawant S.S., Pedersen C.A., and Balkrishnan R. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States. Ann Allergy Asthma Immunol 100 (2008) 216-221
28. Fhärm E., Rolandsson O., and Weinehall L. Guidelines improve general trend of lowered cholesterol levels in type 2 diabetes patients in spite of low adherence. Scand J Public Health 36 (2008) 69-75
29. Jain M.K., Heyland D., Dhaliwal R., Day A.G., Drover J., Keefe L., et al. Dissemination of the Canadian clinical practice guidelines for nutrition support: results of a cluster randomized controlled trial. Crit Care Med 34 (2006) 2362-2369
30. Halna M., Leblond P., Aissi E., Dumonceaux A., Delepoulle F., El Kohen R., et al. Impact de la conférence de consensus sur le traitement ambulatoire des bronchiolites du nourrisson: étude sur trois années dans le département du Nord. Presse Med 34 (2005) 277-281
31. Misset B., Artigas A., Bihari D., Carlet J., Durocher A., Hemmer M., et al. Short-term impact of the European Consensus Conference on the use of selective decontamination of the digestive tract with antibiotics in ICU patients. Intensive Care Med 22 (1996) 981-984
32. Duvaldestin P., Cunin P., Plaud B., and Maison P. Enquête de pratique sur l'utilisation en France des curares chez l'adulte en anesthésie. Ann Fr Anesth Reanim 27 (2008) 483-489